Mitchell S. Cairo is professor of pediatrics, medicine, pathology, microbiology and immunology and cell biology and anatomy, and associate chairman of the Department of Pediatrics at New York Medical College. He earned his medical degree at the the University of Wisconsin and University of California, San Francisco, and he completed a pediatric hematology/oncology fellowship at Indiana University. A researcher and a practicing physician, Dr. Cairo is also chief of pediatric hematology, oncology and stem cell transplantation, and director of the Children and Adolescent Cancer and Blood Diseases Center at Maria Fareri Children’s Hospital at Westchester Medical Center. His work focuses on cancer genetics, tumor immunology, transplantation biology, stem cell biology and regenerative medicine. 

Areas of Expertise

Pediatrics, genetics, and stem cell biology

Publications

• Klejmont, L. M., Mo, X., Milner, J., Harrison, L., Morris, E., van de Ven, C., & Cairo, M. S. (2024). Risk Factors Associated With Survival Following Ganciclovir Prophylaxis Through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated With Significantly Decreased 1-Year Survival. Transplantation and Cellular Therapy, 30 (1), 103.e1-103.e8. https://doi.org/10.1016/j.jtct.2023.09.025
• Finkel, D. A., Malfa, A., Liao, Y., Purohit, D., Hu, F., Sulaymankhil, D., Abhishek Narra, S., Hussein, K., Subbian, S., Cairo, M. S., Vinukonda, G., & La Gamma, E. F. (2023). Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVH. Stem Cells Translational Medicine, 12 (12), 811-824. https://doi.org/https://doi.org/10.1093/stcltm/szad064
• Perissinotti, A. J., Bishop, M. R., Bubalo, J., Geyer, M. B., Goodrich, A., Howard, S. C., Kula, J., Mandayam, S., Cairo, M. S., & Pui, C. (2023). Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel. Cancer Treatment Reviews, 120, 102603. https://doi.org/10.1016/j.ctrv.2023.102603
• Klejmont, L. M., Mo, X., Milner, J., Harrison, L., Morris, E., van de Ven, C., & Cairo, M. S. (2023). Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of CMV Viremia Associated with Significantly Decreased One-Year Survival. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2023.09.025
• Cairo, M. S., Gallagher, J. R., Drea, E. J., Barnes, Y. J., Clark, C., & Carroll, S. (2023). Mortality After Rasburicase vs. Allopurinol Anti-Hyperuricemia Monotherapy in Patients With Liquid Tumors. Annals of Oncology, 34 (Suppl.2), S551-S552. https://doi.org/10.1016/j.annonc.2023.09.711
• Kitko, C. L., Bollard, C. M., Cairo, M. S., Chewning, J., Fry, T. J., Pulsipher, M. A., Shenoy, S., Wall, D. A., & Levine, J. E. (2023). Children's Oncology Group's 2023 Blueprint for Research: Cellular Therapy and Stem Cell Transplantation. Pediatric Blood & Cancer, 70 Suppl 6 (Suppl 6), e30577. https://doi.org/10.1002/pbc.30577
• Cairo, M. S. (2023). "The State of the Science" of Childhood, Adolescent and Young Adult Non Hodgkin Lymphoma (NHL). Best Practice & Research. Clinical Haematology, 36 (2), 101482. https://doi.org/10.1016/j.beha.2023.101482

View All on Touro Scholar

Videos